Europe Acute Myeloid Leukemia (AML) Therapeutic Market Report 2016

Publisher Name :
Date: 15-Nov-2016
No. of pages: 114
Inquire Before Buying

Notes:

Sales, means the sales volume of Acute Myeloid Leukemia (AML) Therapeutic

Revenue, means the sales value of Acute Myeloid Leukemia (AML) Therapeutic

This report studies sales (consumption) of Acute Myeloid Leukemia (AML) Therapeutic in Europe market, especially in Germany, UK, France, Russia, Italy, Benelux and Spain, focuses on top players in these countries, with sales, price, revenue and market share for each player in these Countries, covering

- Ambit Biosciences Inc. (US)

- Aprea AB (Sweden)

- Astellas Pharma Inc. (Japan)

- Astex Pharmaceuticals, Inc. (US)

- Bio-Path Holdings, Inc. (US)

- BioSante Pharmaceuticals, Inc. (US)

- Celator Pharmaceuticals, Inc. (US)

- Celgene Corp. (US)

- Clavis Pharma ASA (Norway)

- Cyclacel Pharmaceuticals, Inc. (US)

- EpiCept Corp. (US)

- Genzyme Corporation (US)

- Lorus Therapeutics, Inc. (Canada)

- Novartis AG (Switzerland)

- Onconova Therapeutics, Inc. (US)

Market Segment by Countries, this report splits Europe into several key Countries, with sales (consumption), revenue, market share and growth rate of Acute Myeloid Leukemia (AML) Therapeutic in these countries, from 2011 to 2021 (forecast), like

- Germany

- France

- UK

- Russia

- Italy

- Spain

- Benelux

Split by product type, with sales, revenue, price, market share and growth rate of each type, can be divided into

- Type I

- Type II

- Type III

Split by application, this report focuses on sales, market share and growth rate of Acute Myeloid Leukemia (AML) Therapeutic in each application, can be divided into

- Application 1

- Application 2

- Application 3

Europe Acute Myeloid Leukemia (AML) Therapeutic Market Report 2016

Table of Contents
Europe Acute Myeloid Leukemia (AML) Therapeutic Market Report 2016
1 Acute Myeloid Leukemia (AML) Therapeutic Overview
1.1 Product Overview and Scope of Acute Myeloid Leukemia (AML) Therapeutic
1.2 Classification of Acute Myeloid Leukemia (AML) Therapeutic
1.2.1 Type I
1.2.2 Type II
1.2.3 Type III
1.3 Application of Acute Myeloid Leukemia (AML) Therapeutic
1.3.1 Application 1
1.3.2 Application 2
1.3.3 Application 3
1.4 Acute Myeloid Leukemia (AML) Therapeutic Market by Countries
1.4.1 Germany Status and Prospect (2011-2021)
1.4.2 France Status and Prospect (2011-2021)
1.4.3 UK Status and Prospect (2011-2021)
1.4.4 Russia Status and Prospect (2011-2021)
1.4.5 Italy Status and Prospect (2011-2021)
1.4.6 Spain Status and Prospect (2011-2021)
1.4.7 Benelux Status and Prospect (2011-2021)
1.5 Europe Market Size (Value and Volume) of Acute Myeloid Leukemia (AML) Therapeutic (2011-2021)
1.5.1 Europe Acute Myeloid Leukemia (AML) Therapeutic Sales and Growth Rate (2011-2021)
1.5.2 Europe Acute Myeloid Leukemia (AML) Therapeutic Revenue and Growth Rate (2011-2021)
2 Europe Acute Myeloid Leukemia (AML) Therapeutic by Manufacturers, Type and Application
2.1 Europe Acute Myeloid Leukemia (AML) Therapeutic Market Competition by Manufacturers
2.1.1 Europe Acute Myeloid Leukemia (AML) Therapeutic Sales and Market Share of Key Manufacturers (2015 and 2016)
2.1.2 Europe Acute Myeloid Leukemia (AML) Therapeutic Revenue and Share by Manufacturers (2015 and 2016)
2.2 Europe Acute Myeloid Leukemia (AML) Therapeutic (Volume and Value) by Type
2.2.1 Europe Acute Myeloid Leukemia (AML) Therapeutic Sales and Market Share by Type (2011-2016)
2.2.2 Europe Acute Myeloid Leukemia (AML) Therapeutic Revenue and Market Share by Type (2011-2016)
2.3 Europe Acute Myeloid Leukemia (AML) Therapeutic (Volume and Value) by Countries
2.3.1 Europe Acute Myeloid Leukemia (AML) Therapeutic Sales and Market Share by Countries (2011-2016)
2.3.2 Europe Acute Myeloid Leukemia (AML) Therapeutic Revenue and Market Share by Countries (2011-2016)
2.4 Europe Acute Myeloid Leukemia (AML) Therapeutic (Volume) by Application
3 Germany Acute Myeloid Leukemia (AML) Therapeutic (Volume, Value and Sales Price)
3.1 Germany Acute Myeloid Leukemia (AML) Therapeutic Sales and Value (2011-2016)
3.1.1 Germany Acute Myeloid Leukemia (AML) Therapeutic Sales and Growth Rate (2011-2016)
3.1.2 Germany Acute Myeloid Leukemia (AML) Therapeutic Revenue and Growth Rate (2011-2016)
3.1.3 Germany Acute Myeloid Leukemia (AML) Therapeutic Sales Price Trend (2011-2016)
3.2 Germany Acute Myeloid Leukemia (AML) Therapeutic Sales and Market Share by Manufacturers
3.3 Germany Acute Myeloid Leukemia (AML) Therapeutic Sales and Market Share by Type
3.4 Germany Acute Myeloid Leukemia (AML) Therapeutic Sales and Market Share by Application
4 France Acute Myeloid Leukemia (AML) Therapeutic (Volume, Value and Sales Price)
4.1 France Acute Myeloid Leukemia (AML) Therapeutic Sales and Value (2011-2016)
4.1.1 France Acute Myeloid Leukemia (AML) Therapeutic Sales and Growth Rate (2011-2016)
4.1.2 France Acute Myeloid Leukemia (AML) Therapeutic Revenue and Growth Rate (2011-2016)
4.1.4 France Acute Myeloid Leukemia (AML) Therapeutic Sales Price Trend (2011-2016)
4.2 France Acute Myeloid Leukemia (AML) Therapeutic Sales and Market Share by Manufacturers
4.3 France Acute Myeloid Leukemia (AML) Therapeutic Sales and Market Share by Type
4.4 France Acute Myeloid Leukemia (AML) Therapeutic Sales and Market Share by Application
5 UK Acute Myeloid Leukemia (AML) Therapeutic (Volume, Value and Sales Price)
5.1 UK Acute Myeloid Leukemia (AML) Therapeutic Sales and Value (2011-2016)
5.1.1 UK Acute Myeloid Leukemia (AML) Therapeutic Sales and Growth Rate (2011-2016)
5.1.2 UK Acute Myeloid Leukemia (AML) Therapeutic Revenue and Growth Rate (2011-2016)
5.1.5 UK Acute Myeloid Leukemia (AML) Therapeutic Sales Price Trend (2011-2016)
5.2 UK Acute Myeloid Leukemia (AML) Therapeutic Sales and Market Share by Manufacturers
5.3 UK Acute Myeloid Leukemia (AML) Therapeutic Sales and Market Share by Type
5.4 UK Acute Myeloid Leukemia (AML) Therapeutic Sales and Market Share by Application
6 Russia Acute Myeloid Leukemia (AML) Therapeutic (Volume, Value and Sales Price)
6.1 Russia Acute Myeloid Leukemia (AML) Therapeutic Sales and Value (2011-2016)
6.1.1 Russia Acute Myeloid Leukemia (AML) Therapeutic Sales and Growth Rate (2011-2016)
6.1.2 Russia Acute Myeloid Leukemia (AML) Therapeutic Revenue and Growth Rate (2011-2016)
6.1.6 Russia Acute Myeloid Leukemia (AML) Therapeutic Sales Price Trend (2011-2016)
6.2 Russia Acute Myeloid Leukemia (AML) Therapeutic Sales and Market Share by Manufacturers
6.3 Russia Acute Myeloid Leukemia (AML) Therapeutic Sales and Market Share by Type
6.4 Russia Acute Myeloid Leukemia (AML) Therapeutic Sales and Market Share by Application
7 Italy Acute Myeloid Leukemia (AML) Therapeutic (Volume, Value and Sales Price)
7.1 Italy Acute Myeloid Leukemia (AML) Therapeutic Sales and Value (2011-2016)
7.1.1 Italy Acute Myeloid Leukemia (AML) Therapeutic Sales and Growth Rate (2011-2016)
7.1.2 Italy Acute Myeloid Leukemia (AML) Therapeutic Revenue and Growth Rate (2011-2016)
7.1.7 Italy Acute Myeloid Leukemia (AML) Therapeutic Sales Price Trend (2011-2016)
7.2 Italy Acute Myeloid Leukemia (AML) Therapeutic Sales and Market Share by Manufacturers
7.3 Italy Acute Myeloid Leukemia (AML) Therapeutic Sales and Market Share by Type
7.4 Italy Acute Myeloid Leukemia (AML) Therapeutic Sales and Market Share by Application
8 Spain Acute Myeloid Leukemia (AML) Therapeutic (Volume, Value and Sales Price)
8.1 Spain Acute Myeloid Leukemia (AML) Therapeutic Sales and Value (2011-2016)
8.1.1 Spain Acute Myeloid Leukemia (AML) Therapeutic Sales and Growth Rate (2011-2016)
8.1.2 Spain Acute Myeloid Leukemia (AML) Therapeutic Revenue and Growth Rate (2011-2016)
8.1.8 Spain Acute Myeloid Leukemia (AML) Therapeutic Sales Price Trend (2011-2016)
8.2 Spain Acute Myeloid Leukemia (AML) Therapeutic Sales and Market Share by Manufacturers
8.3 Spain Acute Myeloid Leukemia (AML) Therapeutic Sales and Market Share by Type
8.4 Spain Acute Myeloid Leukemia (AML) Therapeutic Sales and Market Share by Application
9 Benelux Acute Myeloid Leukemia (AML) Therapeutic (Volume, Value and Sales Price)
9.1 Benelux Acute Myeloid Leukemia (AML) Therapeutic Sales and Value (2011-2016)
9.1.1 Benelux Acute Myeloid Leukemia (AML) Therapeutic Sales and Growth Rate (2011-2016)
9.1.2 Benelux Acute Myeloid Leukemia (AML) Therapeutic Revenue and Growth Rate (2011-2016)
9.1.9 Benelux Acute Myeloid Leukemia (AML) Therapeutic Sales Price Trend (2011-2016)
9.2 Benelux Acute Myeloid Leukemia (AML) Therapeutic Sales and Market Share by Manufacturers
9.3 Benelux Acute Myeloid Leukemia (AML) Therapeutic Sales and Market Share by Type
9.4 Benelux Acute Myeloid Leukemia (AML) Therapeutic Sales and Market Share by Application
10 Europe Acute Myeloid Leukemia (AML) Therapeutic Manufacturers Analysis
10.1 Ambit Biosciences Inc. (US)
10.1.1 Company Basic Information, Manufacturing Base and Competitors
10.1.2 Acute Myeloid Leukemia (AML) Therapeutic Product Type, Application and Specification
10.1.2.1 Type I
10.1.2.2 Type II
10.1.3 Ambit Biosciences Inc. (US) Acute Myeloid Leukemia (AML) Therapeutic Sales, Revenue, Price and Gross Margin (2011-2016)
10.1.4 Main Business/Business Overview
10.2 Aprea AB (Sweden)
10.2.1 Company Basic Information, Manufacturing Base and Competitors
10.2.2 Acute Myeloid Leukemia (AML) Therapeutic Product Type, Application and Specification
10.2.2.1 Type I
10.2.2.2 Type II
10.2.3 Aprea AB (Sweden) Acute Myeloid Leukemia (AML) Therapeutic Sales, Revenue, Price and Gross Margin (2011-2016)
10.2.4 Main Business/Business Overview
10.3 Astellas Pharma Inc. (Japan)
10.3.1 Company Basic Information, Manufacturing Base and Competitors
10.3.2 Acute Myeloid Leukemia (AML) Therapeutic Product Type, Application and Specification
10.3.2.1 Type I
10.3.2.2 Type II
10.3.3 Astellas Pharma Inc. (Japan) Acute Myeloid Leukemia (AML) Therapeutic Sales, Revenue, Price and Gross Margin (2011-2016)
10.3.4 Main Business/Business Overview
10.4 Astex Pharmaceuticals, Inc. (US)
10.4.1 Company Basic Information, Manufacturing Base and Competitors
10.4.2 Acute Myeloid Leukemia (AML) Therapeutic Product Type, Application and Specification
10.4.2.1 Type I
10.4.2.2 Type II
10.4.3 Astex Pharmaceuticals, Inc. (US) Acute Myeloid Leukemia (AML) Therapeutic Sales, Revenue, Price and Gross Margin (2011-2016)
10.4.4 Main Business/Business Overview
10.5 Bio-Path Holdings, Inc. (US)
10.5.1 Company Basic Information, Manufacturing Base and Competitors
10.5.2 Acute Myeloid Leukemia (AML) Therapeutic Product Type, Application and Specification
10.5.2.1 Type I
10.5.2.2 Type II
10.5.3 Bio-Path Holdings, Inc. (US) Acute Myeloid Leukemia (AML) Therapeutic Sales, Revenue, Price and Gross Margin (2011-2016)
10.5.4 Main Business/Business Overview
10.6 BioSante Pharmaceuticals, Inc. (US)
10.6.1 Company Basic Information, Manufacturing Base and Competitors
10.6.2 Acute Myeloid Leukemia (AML) Therapeutic Product Type, Application and Specification
10.6.2.1 Type I
10.6.2.2 Type II
10.6.3 BioSante Pharmaceuticals, Inc. (US) Acute Myeloid Leukemia (AML) Therapeutic Sales, Revenue, Price and Gross Margin (2011-2016)
10.6.4 Main Business/Business Overview
10.7 Celator Pharmaceuticals, Inc. (US)
10.7.1 Company Basic Information, Manufacturing Base and Competitors
10.7.2 Acute Myeloid Leukemia (AML) Therapeutic Product Type, Application and Specification
10.7.2.1 Type I
10.7.2.2 Type II
10.7.3 Celator Pharmaceuticals, Inc. (US) Acute Myeloid Leukemia (AML) Therapeutic Sales, Revenue, Price and Gross Margin (2011-2016)
10.7.4 Main Business/Business Overview
10.8 Celgene Corp. (US)
10.8.1 Company Basic Information, Manufacturing Base and Competitors
10.8.2 Acute Myeloid Leukemia (AML) Therapeutic Product Type, Application and Specification
10.8.2.1 Type I
10.8.2.2 Type II
10.8.3 Celgene Corp. (US) Acute Myeloid Leukemia (AML) Therapeutic Sales, Revenue, Price and Gross Margin (2011-2016)
10.8.4 Main Business/Business Overview
10.9 Clavis Pharma ASA (Norway)
10.9.1 Company Basic Information, Manufacturing Base and Competitors
10.9.2 Acute Myeloid Leukemia (AML) Therapeutic Product Type, Application and Specification
10.9.2.1 Type I
10.9.2.2 Type II
10.9.3 Clavis Pharma ASA (Norway) Acute Myeloid Leukemia (AML) Therapeutic Sales, Revenue, Price and Gross Margin (2011-2016)
10.9.4 Main Business/Business Overview
10.10 Cyclacel Pharmaceuticals, Inc. (US)
10.10.1 Company Basic Information, Manufacturing Base and Competitors
10.10.2 Acute Myeloid Leukemia (AML) Therapeutic Product Type, Application and Specification
10.10.2.1 Type I
10.10.2.2 Type II
10.10.3 Cyclacel Pharmaceuticals, Inc. (US) Acute Myeloid Leukemia (AML) Therapeutic Sales, Revenue, Price and Gross Margin (2011-2016)
10.10.4 Main Business/Business Overview
10.11 EpiCept Corp. (US)
10.12 Genzyme Corporation (US)
10.13 Lorus Therapeutics, Inc. (Canada)
10.14 Novartis AG (Switzerland)
10.15 Onconova Therapeutics, Inc. (US)
11 Acute Myeloid Leukemia (AML) Therapeutic Manufacturing Cost Analysis
11.1 Acute Myeloid Leukemia (AML) Therapeutic Key Raw Materials Analysis
11.1.1 Key Raw Materials
11.1.2 Price Trend of Key Raw Materials
11.1.3 Key Suppliers of Raw Materials
11.1.4 Market Concentration Rate of Raw Materials
11.2 Proportion of Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 Manufacturing Process Analysis of Acute Myeloid Leukemia (AML) Therapeutic
12 Industrial Chain, Sourcing Strategy and Downstream Buyers
12.1 Acute Myeloid Leukemia (AML) Therapeutic Industrial Chain Analysis
12.2 Upstream Raw Materials Sourcing
12.3 Raw Materials Sources of Acute Myeloid Leukemia (AML) Therapeutic Major Manufacturers in 2015
12.4 Downstream Buyers
13 Marketing Strategy Analysis, Distributors/Traders
13.1 Marketing Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.1.3 Marketing Channel Development Trend
13.2 Market Positioning
13.2.1 Pricing Strategy
13.2.2 Brand Strategy
13.2.3 Target Client
13.3 Distributors/Traders List
14 Europe Acute Myeloid Leukemia (AML) Therapeutic Market Forecast (2016-2021)
14.1 Germany Acute Myeloid Leukemia (AML) Therapeutic Sales Forecast (2016-2021)
14.2 France Acute Myeloid Leukemia (AML) Therapeutic Sales Forecast (2016-2021)
14.3 UK Acute Myeloid Leukemia (AML) Therapeutic Sales Forecast (2016-2021)
14.4 Russia Acute Myeloid Leukemia (AML) Therapeutic Sales Forecast (2016-2021)
14.5 Italy Acute Myeloid Leukemia (AML) Therapeutic Sales Forecast (2016-2021)
14.6 Spain Acute Myeloid Leukemia (AML) Therapeutic Sales Forecast (2016-2021)
14.7 Benelux Acute Myeloid Leukemia (AML) Therapeutic Sales Forecast (2016-2021)
14.8 Europe Acute Myeloid Leukemia (AML) Therapeutic Sales Forecast by Type (2016-2021)
14.9 Europe Acute Myeloid Leukemia (AML) Therapeutic Sales Forecast by Application (2016-2021)
15 Research Findings and Conclusion
16 Appendix
Author List
Disclosure Section
Research Methodology
Data Source
Disclaimer
List of Tables and Figures
Figure Picture of Acute Myeloid Leukemia (AML) Therapeutic
Table Classification of Acute Myeloid Leukemia (AML) Therapeutic
Figure Europe Sales Market Share of Acute Myeloid Leukemia (AML) Therapeutic by Type in 2015
Figure Type I Picture
Figure Type II Picture
Table Application of Acute Myeloid Leukemia (AML) Therapeutic
Figure Europe Sales Market Share of Acute Myeloid Leukemia (AML) Therapeutic by Application in 2015
Figure Application 1 Examples
Figure Application 2 Examples
Figure Germany Acute Myeloid Leukemia (AML) Therapeutic Revenue and Growth Rate (2011-2021)
Figure France Acute Myeloid Leukemia (AML) Therapeutic Revenue and Growth Rate (2011-2021)
Figure UK Acute Myeloid Leukemia (AML) Therapeutic Revenue and Growth Rate (2011-2021)
Figure Russia Acute Myeloid Leukemia (AML) Therapeutic Revenue and Growth Rate (2011-2021)
Figure Italy Acute Myeloid Leukemia (AML) Therapeutic Revenue and Growth Rate (2011-2021)
Figure Spain Acute Myeloid Leukemia (AML) Therapeutic Revenue and Growth Rate (2011-2021)
Figure Benelux Acute Myeloid Leukemia (AML) Therapeutic Revenue and Growth Rate (2011-2021)
Figure Europe Acute Myeloid Leukemia (AML) Therapeutic Sales and Growth Rate (2011-2021)
Figure Europe Acute Myeloid Leukemia (AML) Therapeutic Revenue and Growth Rate (2011-2021)
Table Europe Acute Myeloid Leukemia (AML) Therapeutic Sales of Key Manufacturers (2015 and 2016)
Table Europe Acute Myeloid Leukemia (AML) Therapeutic Sales Share by Manufacturers (2015 and 2016)
Figure 2015 Acute Myeloid Leukemia (AML) Therapeutic Sales Share by Manufacturers
Figure 2016 Acute Myeloid Leukemia (AML) Therapeutic Sales Share by Manufacturers
Table Europe Acute Myeloid Leukemia (AML) Therapeutic Revenue by Manufacturers (2015 and 2016)
Table Europe Acute Myeloid Leukemia (AML) Therapeutic Revenue Share by Manufacturers (2015 and 2016)
Table 2015 Europe Acute Myeloid Leukemia (AML) Therapeutic Revenue Share by Manufacturers
Table 2016 Europe Acute Myeloid Leukemia (AML) Therapeutic Revenue Share by Manufacturers
Table Europe Acute Myeloid Leukemia (AML) Therapeutic Sales and Market Share by Type (2011-2016)
Table Europe Acute Myeloid Leukemia (AML) Therapeutic Sales Share by Type (2011-2016)
Figure Sales Market Share of Acute Myeloid Leukemia (AML) Therapeutic by Type (2011-2016)
Figure Europe Acute Myeloid Leukemia (AML) Therapeutic Sales Growth Rate by Type (2011-2016)
Table Europe Acute Myeloid Leukemia (AML) Therapeutic Revenue and Market Share by Type (2011-2016)
Table Europe Acute Myeloid Leukemia (AML) Therapeutic Revenue Share by Type (2011-2016)
Figure Revenue Market Share of Acute Myeloid Leukemia (AML) Therapeutic by Type (2011-2016)
Figure Europe Acute Myeloid Leukemia (AML) Therapeutic Revenue Growth Rate by Type (2011-2016)
Table Europe Acute Myeloid Leukemia (AML) Therapeutic Sales and Market Share by Countries (2011-2016)
Table Europe Acute Myeloid Leukemia (AML) Therapeutic Sales Share by Countries (2011-2016)
Figure Sales Market Share of Acute Myeloid Leukemia (AML) Therapeutic by Countries (2011-2016)
Table Europe Acute Myeloid Leukemia (AML) Therapeutic Revenue and Market Share by Countries (2011-2016)
Table Europe Acute Myeloid Leukemia (AML) Therapeutic Revenue Share by Countries (2011-2016)
Figure Revenue Market Share of Acute Myeloid Leukemia (AML) Therapeutic by Countries (2011-2016)
Table Europe Acute Myeloid Leukemia (AML) Therapeutic Sales and Market Share by Application (2011-2016)
Table Europe Acute Myeloid Leukemia (AML) Therapeutic Sales Share by Application (2011-2016)
Figure Sales Market Share of Acute Myeloid Leukemia (AML) Therapeutic by Application (2011-2016)
Figure Germany Acute Myeloid Leukemia (AML) Therapeutic Sales and Growth Rate (2011-2016)
Figure Germany Acute Myeloid Leukemia (AML) Therapeutic Revenue and Growth Rate (2011-2016)
Figure Germany Acute Myeloid Leukemia (AML) Therapeutic Sales Price Trend (2011-2016)
Table Germany Acute Myeloid Leukemia (AML) Therapeutic Sales by Manufacturers (2015 and 2016)
Table Germany Acute Myeloid Leukemia (AML) Therapeutic Market Share by Manufacturers (2015 and 2016)
Table Germany Acute Myeloid Leukemia (AML) Therapeutic Sales by Type (2015 and 2016)
Table Germany Acute Myeloid Leukemia (AML) Therapeutic Market Share by Type (2015 and 2016)
Table Germany Acute Myeloid Leukemia (AML) Therapeutic Sales by Application (2015 and 2016)
Table Germany Acute Myeloid Leukemia (AML) Therapeutic Market Share by Application (2015 and 2016)
Figure France Acute Myeloid Leukemia (AML) Therapeutic Sales and Growth Rate (2011-2016)
Figure France Acute Myeloid Leukemia (AML) Therapeutic Revenue and Growth Rate (2011-2016)
Figure France Acute Myeloid Leukemia (AML) Therapeutic Sales Price Trend (2011-2016)
Table France Acute Myeloid Leukemia (AML) Therapeutic Sales by Manufacturers (2015 and 2016)
Table France Acute Myeloid Leukemia (AML) Therapeutic Market Share by Manufacturers (2015 and 2016)
Table France Acute Myeloid Leukemia (AML) Therapeutic Sales by Type (2015 and 2016)
Table France Acute Myeloid Leukemia (AML) Therapeutic Market Share by Type (2015 and 2016)
Table France Acute Myeloid Leukemia (AML) Therapeutic Sales by Application (2015 and 2016)
Table France Acute Myeloid Leukemia (AML) Therapeutic Market Share by Application (2015 and 2016)
Figure UK Acute Myeloid Leukemia (AML) Therapeutic Sales and Growth Rate (2011-2016)
Figure UK Acute Myeloid Leukemia (AML) Therapeutic Revenue and Growth Rate (2011-2016)
Figure UK Acute Myeloid Leukemia (AML) Therapeutic Sales Price Trend (2011-2016)
Table UK Acute Myeloid Leukemia (AML) Therapeutic Sales by Manufacturers (2015 and 2016)
Table UK Acute Myeloid Leukemia (AML) Therapeutic Market Share by Manufacturers (2015 and 2016)
Table UK Acute Myeloid Leukemia (AML) Therapeutic Sales by Type (2015 and 2016)
Table UK Acute Myeloid Leukemia (AML) Therapeutic Market Share by Type (2015 and 2016)
Table UK Acute Myeloid Leukemia (AML) Therapeutic Sales by Application (2015 and 2016)
Table UK Acute Myeloid Leukemia (AML) Therapeutic Market Share by Application (2015 and 2016)
Figure Russia Acute Myeloid Leukemia (AML) Therapeutic Sales and Growth Rate (2011-2016)
Figure Russia Acute Myeloid Leukemia (AML) Therapeutic Revenue and Growth Rate (2011-2016)
Figure Russia Acute Myeloid Leukemia (AML) Therapeutic Sales Price Trend (2011-2016)
Table Russia Acute Myeloid Leukemia (AML) Therapeutic Sales by Manufacturers (2015 and 2016)
Table Russia Acute Myeloid Leukemia (AML) Therapeutic Market Share by Manufacturers (2015 and 2016)
Table Russia Acute Myeloid Leukemia (AML) Therapeutic Sales by Type (2015 and 2016)
Table Russia Acute Myeloid Leukemia (AML) Therapeutic Market Share by Type (2015 and 2016)
Table Russia Acute Myeloid Leukemia (AML) Therapeutic Sales by Application (2015 and 2016)
Table Russia Acute Myeloid Leukemia (AML) Therapeutic Market Share by Application (2015 and 2016)
Figure Italy Acute Myeloid Leukemia (AML) Therapeutic Sales and Growth Rate (2011-2016)
Figure Italy Acute Myeloid Leukemia (AML) Therapeutic Revenue and Growth Rate (2011-2016)
Figure Italy Acute Myeloid Leukemia (AML) Therapeutic Sales Price Trend (2011-2016)
Table Italy Acute Myeloid Leukemia (AML) Therapeutic Sales by Manufacturers (2015 and 2016)
Table Italy Acute Myeloid Leukemia (AML) Therapeutic Market Share by Manufacturers (2015 and 2016)
Table Italy Acute Myeloid Leukemia (AML) Therapeutic Sales by Type (2015 and 2016)
Table Italy Acute Myeloid Leukemia (AML) Therapeutic Market Share by Type (2015 and 2016)
Table Italy Acute Myeloid Leukemia (AML) Therapeutic Sales by Application (2015 and 2016)
Table Italy Acute Myeloid Leukemia (AML) Therapeutic Market Share by Application (2015 and 2016)
Figure Spain Acute Myeloid Leukemia (AML) Therapeutic Sales and Growth Rate (2011-2016)
Figure Spain Acute Myeloid Leukemia (AML) Therapeutic Revenue and Growth Rate (2011-2016)
Figure Spain Acute Myeloid Leukemia (AML) Therapeutic Sales Price Trend (2011-2016)
Table Spain Acute Myeloid Leukemia (AML) Therapeutic Sales by Manufacturers (2015 and 2016)
Table Spain Acute Myeloid Leukemia (AML) Therapeutic Market Share by Manufacturers (2015 and 2016)
Table Spain Acute Myeloid Leukemia (AML) Therapeutic Sales by Type (2015 and 2016)
Table Spain Acute Myeloid Leukemia (AML) Therapeutic Market Share by Type (2015 and 2016)
Table Spain Acute Myeloid Leukemia (AML) Therapeutic Sales by Application (2015 and 2016)
Table Spain Acute Myeloid Leukemia (AML) Therapeutic Market Share by Application (2015 and 2016)
Figure Benelux Acute Myeloid Leukemia (AML) Therapeutic Sales and Growth Rate (2011-2016)
Figure Benelux Acute Myeloid Leukemia (AML) Therapeutic Revenue and Growth Rate (2011-2016)
Figure Benelux Acute Myeloid Leukemia (AML) Therapeutic Sales Price Trend (2011-2016)
Table Benelux Acute Myeloid Leukemia (AML) Therapeutic Sales by Manufacturers (2015 and 2016)
Table Benelux Acute Myeloid Leukemia (AML) Therapeutic Market Share by Manufacturers (2015 and 2016)
Table Benelux Acute Myeloid Leukemia (AML) Therapeutic Sales by Type (2015 and 2016)
Table Benelux Acute Myeloid Leukemia (AML) Therapeutic Market Share by Type (2015 and 2016)
Table Benelux Acute Myeloid Leukemia (AML) Therapeutic Sales by Application (2015 and 2016)
Table Benelux Acute Myeloid Leukemia (AML) Therapeutic Market Share by Application (2015 and 2016)
Table Acute Myeloid Leukemia (AML) Therapeutic Basic Information List
Table Ambit Biosciences Inc. (US) Acute Myeloid Leukemia (AML) Therapeutic Sales, Revenue, Price and Gross Margin (2011-2016)
Figure Ambit Biosciences Inc. (US) Acute Myeloid Leukemia (AML) Therapeutic Sales Market Share (2011-2016)
Table Aprea AB (Sweden) Basic Information List
Table Aprea AB (Sweden) Acute Myeloid Leukemia (AML) Therapeutic Sales, Revenue, Price and Gross Margin (2011-2016)
Table Aprea AB (Sweden) Acute Myeloid Leukemia (AML) Therapeutic Sales Market Share (2011-2016)
Table Astellas Pharma Inc. (Japan) Basic Information List
Table Astellas Pharma Inc. (Japan) Acute Myeloid Leukemia (AML) Therapeutic Sales, Revenue, Price and Gross Margin (2011-2016)
Table Astellas Pharma Inc. (Japan) Acute Myeloid Leukemia (AML) Therapeutic Sales Market Share (2011-2016)
Table Astex Pharmaceuticals, Inc. (US) Basic Information List
Table Astex Pharmaceuticals, Inc. (US) Acute Myeloid Leukemia (AML) Therapeutic Sales, Revenue, Price and Gross Margin (2011-2016)
Table Astex Pharmaceuticals, Inc. (US) Acute Myeloid Leukemia (AML) Therapeutic Sales Market Share (2011-2016)
Table Bio-Path Holdings, Inc. (US) Basic Information List
Table Bio-Path Holdings, Inc. (US) Acute Myeloid Leukemia (AML) Therapeutic Sales, Revenue, Price and Gross Margin (2011-2016)
Table Bio-Path Holdings, Inc. (US) Acute Myeloid Leukemia (AML) Therapeutic Sales Market Share (2011-2016)
Table BioSante Pharmaceuticals, Inc. (US) Basic Information List
Table BioSante Pharmaceuticals, Inc. (US) Acute Myeloid Leukemia (AML) Therapeutic Sales, Revenue, Price and Gross Margin (2011-2016)
Table BioSante Pharmaceuticals, Inc. (US) Acute Myeloid Leukemia (AML) Therapeutic Sales Market Share (2011-2016)
Table Celator Pharmaceuticals, Inc. (US) Basic Information List
Table Celator Pharmaceuticals, Inc. (US) Acute Myeloid Leukemia (AML) Therapeutic Sales, Revenue, Price and Gross Margin (2011-2016)
Table Celator Pharmaceuticals, Inc. (US) Acute Myeloid Leukemia (AML) Therapeutic Sales Market Share (2011-2016)
Table Celgene Corp. (US) Basic Information List
Table Celgene Corp. (US) Acute Myeloid Leukemia (AML) Therapeutic Sales, Revenue, Price and Gross Margin (2011-2016)
Table Celgene Corp. (US) Acute Myeloid Leukemia (AML) Therapeutic Sales Market Share (2011-2016)
Table Clavis Pharma ASA (Norway) Basic Information List
Table Clavis Pharma ASA (Norway) Acute Myeloid Leukemia (AML) Therapeutic Sales, Revenue, Price and Gross Margin (2011-2016)
Table Clavis Pharma ASA (Norway) Acute Myeloid Leukemia (AML) Therapeutic Sales Market Share (2011-2016)
Table Cyclacel Pharmaceuticals, Inc. (US) Basic Information List
Table Cyclacel Pharmaceuticals, Inc. (US) Acute Myeloid Leukemia (AML) Therapeutic Sales, Revenue, Price and Gross Margin (2011-2016)
Table Cyclacel Pharmaceuticals, Inc. (US) Acute Myeloid Leukemia (AML) Therapeutic Sales Market Share (2011-2016)
Table EpiCept Corp. (US) Basic Information List
Table EpiCept Corp. (US) Acute Myeloid Leukemia (AML) Therapeutic Sales, Revenue, Price and Gross Margin (2011-2016)
Table EpiCept Corp. (US) Acute Myeloid Leukemia (AML) Therapeutic Sales Market Share (2011-2016)
Table Genzyme Corporation (US) Basic Information List
Table Genzyme Corporation (US) Acute Myeloid Leukemia (AML) Therapeutic Sales, Revenue, Price and Gross Margin (2011-2016)
Table Genzyme Corporation (US) Acute Myeloid Leukemia (AML) Therapeutic Sales Market Share (2011-2016)
Table Lorus Therapeutics, Inc. (Canada) Basic Information List
Table Lorus Therapeutics, Inc. (Canada) Acute Myeloid Leukemia (AML) Therapeutic Sales, Revenue, Price and Gross Margin (2011-2016)
Table Lorus Therapeutics, Inc. (Canada) Acute Myeloid Leukemia (AML) Therapeutic Sales Market Share (2011-2016)
Table Novartis AG (Switzerland) Basic Information List
Table Novartis AG (Switzerland) Acute Myeloid Leukemia (AML) Therapeutic Sales, Revenue, Price and Gross Margin (2011-2016)
Table Novartis AG (Switzerland) Acute Myeloid Leukemia (AML) Therapeutic Sales Market Share (2011-2016)
Table Onconova Therapeutics, Inc. (US) Basic Information List
Table Onconova Therapeutics, Inc. (US) Acute Myeloid Leukemia (AML) Therapeutic Sales, Revenue, Price and Gross Margin (2011-2016)
Table Onconova Therapeutics, Inc. (US) Acute Myeloid Leukemia (AML) Therapeutic Sales Market Share (2011-2016)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Acute Myeloid Leukemia (AML) Therapeutic
Figure Manufacturing Process Analysis of Acute Myeloid Leukemia (AML) Therapeutic
Figure Acute Myeloid Leukemia (AML) Therapeutic Industrial Chain Analysis
Table Raw Materials Sources of Acute Myeloid Leukemia (AML) Therapeutic Major Manufacturers in 2015
Table Major Buyers of Acute Myeloid Leukemia (AML) Therapeutic
Table Distributors/Traders List
Figure Germany Acute Myeloid Leukemia (AML) Therapeutic Sales and Growth Rate Forecast (2016-2021)
Figure Germany Acute Myeloid Leukemia (AML) Therapeutic Revenue and Growth Rate Forecast (2016-2021)
Figure France Acute Myeloid Leukemia (AML) Therapeutic Sales and Growth Rate Forecast (2016-2021)
Figure France Acute Myeloid Leukemia (AML) Therapeutic Revenue and Growth Rate Forecast (2016-2021)
Figure UK Acute Myeloid Leukemia (AML) Therapeutic Sales and Growth Rate Forecast (2016-2021)
Figure UK Acute Myeloid Leukemia (AML) Therapeutic Revenue and Growth Rate Forecast (2016-2021)
Figure Russia Acute Myeloid Leukemia (AML) Therapeutic Sales and Growth Rate Forecast (2016-2021)
Figure Russia Acute Myeloid Leukemia (AML) Therapeutic Revenue and Growth Rate Forecast (2016-2021)
Figure Italy Acute Myeloid Leukemia (AML) Therapeutic Sales and Growth Rate Forecast (2016-2021)
Figure Italy Acute Myeloid Leukemia (AML) Therapeutic Revenue and Growth Rate Forecast (2016-2021)
Figure Spain Acute Myeloid Leukemia (AML) Therapeutic Sales and Growth Rate Forecast (2016-2021)
Figure Spain Acute Myeloid Leukemia (AML) Therapeutic Revenue and Growth Rate Forecast (2016-2021)
Figure Benelux Acute Myeloid Leukemia (AML) Therapeutic Sales and Growth Rate Forecast (2016-2021)
Figure Benelux Acute Myeloid Leukemia (AML) Therapeutic Revenue and Growth Rate Forecast (2016-2021)
Table Europe Acute Myeloid Leukemia (AML) Therapeutic Sales Forecast by Type (2016-2021)
Table Europe Acute Myeloid Leukemia (AML) Therapeutic Sales Forecast by Application (2016-2021)
  • United States, EU, Japan, China, India and Southeast Asia Pharmacy Automation Market Size, Status and Forecast 2021
    Published: 05-Dec-2016        Price: US 3300 Onwards        Pages: 106
    Notes: Production, means the output of Pharmacy Automation Revenue, means the sales value of Pharmacy Automation This report studies the global Pharmacy Automation market, analyzes and researches the Pharmacy Automation development status and forecast in United States, EU, Japan, China, India and Southeast Asia. This report focuses on the top players in global market, like - BD - Baxter International - TOSHO - Takazono - Omnicell......
  • Global Interventional Oncology Device Sales Market Report 2016
    Published: 01-Dec-2016        Price: US 4000 Onwards        Pages: 102
    Notes: Sales, means the sales volume of Interventional Oncology Device Revenue, means the sales value of Interventional Oncology Device This report studies sales (consumption) of Interventional Oncology Device in Global market, especially in United States, China, Europe, Japan, focuses on top players in these regions/countries, with sales, price, revenue and market share for each player in these regions, covering - Philips Volcano - Boston Scientific......
  • Global Intranasal Corticosteroids Sales Market Report 2016
    Published: 01-Dec-2016        Price: US 4000 Onwards        Pages: 102
    Notes: Sales, means the sales volume of Intranasal Corticosteroids Revenue, means the sales value of Intranasal Corticosteroids This report studies sales (consumption) of Intranasal Corticosteroids in Global market, especially in United States, China, Europe, Japan, focuses on top players in these regions/countries, with sales, price, revenue and market share for each player in these regions, covering - GSK - Merck - Sanofi - Johnson & Joh......
  • Global Interventional Oncology Devices Sales Market Report 2016
    Published: 01-Dec-2016        Price: US 4000 Onwards        Pages: 117
    Notes: Sales, means the sales volume of Interventional Oncology Devices Revenue, means the sales value of Interventional Oncology Devices This report studies sales (consumption) of Interventional Oncology Devices in Global market, especially in United States, China, Europe, Japan, focuses on top players in these regions/countries, with sales, price, revenue and market share for each player in these regions, covering - Philips Volcano - Boston Scientific......
  • Global Leukotriene Receptor Antagonist Sales Market Report 2016
    Published: 01-Dec-2016        Price: US 4000 Onwards        Pages: 103
    Notes: Sales, means the sales volume of Leukotriene Receptor Antagonist Revenue, means the sales value of Leukotriene Receptor Antagonist This report studies sales (consumption) of Leukotriene Receptor Antagonist in Global market, especially in United States, China, Europe, Japan, focuses on top players in these regions/countries, with sales, price, revenue and market share for each player in these regions, covering - GSK - Merck - Sanofi ......
  • United States Drugs for Non-small Cell Lung Cancer Market Report 2016
    Published: 01-Dec-2016        Price: US 3800 Onwards        Pages: 118
    Notes: Sales, means the sales volume of Drugs for Non-small Cell Lung Cancer Revenue, means the sales value of Drugs for Non-small Cell Lung Cancer This report studies sales (consumption) of Drugs for Non-small Cell Lung Cancer in United States market, focuses on the top players, with sales, price, revenue and market share for each player, covering - Bristol-Myers Squibb - GlaxoSmithKline - Menarini - Sanofi - ZIOPHARM Oncology......
  • Global Levocetirizine Sales Market Report 2016
    Published: 01-Dec-2016        Price: US 4000 Onwards        Pages: 102
    Notes: Sales, means the sales volume of Levocetirizine Revenue, means the sales value of Levocetirizine This report studies sales (consumption) of Levocetirizine in Global market, especially in United States, China, Europe, Japan, focuses on top players in these regions/countries, with sales, price, revenue and market share for each player in these regions, covering - Sanofi - GlaxoSmithKline - ... Market Segment by Regions, this report sp......
  • Global Oral Antihistamines Sales Market Report 2016
    Published: 01-Dec-2016        Price: US 4000 Onwards        Pages: 100
    Notes: Sales, means the sales volume of Oral Antihistamines Revenue, means the sales value of Oral Antihistamines This report studies sales (consumption) of Oral Antihistamines in Global market, especially in United States, China, Europe, Japan, focuses on top players in these regions/countries, with sales, price, revenue and market share for each player in these regions, covering - GSK - Merck - Sanofi - Johnson & Johnson - ALK-Abe......
  • Global Pembrolizumab Sales Market Report 2016
    Published: 01-Dec-2016        Price: US 4000 Onwards        Pages: 105
    Notes: Sales, means the sales volume of Pembrolizumab Revenue, means the sales value of Pembrolizumab This report studies sales (consumption) of Pembrolizumab in Global market, especially in United States, China, Europe, Japan, focuses on top players in these regions/countries, with sales, price, revenue and market share for each player in these regions, covering - Merck & Co., Inc. - Novartis AG - Onxeo SA - Sumitomo Dainippon Pharma Co.,......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - sales@rnrmarketresearch.com / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs